正济药业 (874229.OC)

+ 收藏

利润表(正济药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2026年中报2025年年报2025年中报2024年年报2024年中报2024年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 会员可见会员可见会员可见会员可见411,467,868.50207,285,527.32
 营业收入(元) 会员可见会员可见会员可见会员可见411,467,868.50207,285,527.32
二、营业总成本(元) 会员可见会员可见会员可见会员可见367,574,239.09184,062,964.10
 营业成本(元) 会员可见会员可见会员可见会员可见258,719,408.96127,513,485.87
 研发费用(元) 会员可见会员可见会员可见会员可见37,580,608.2918,460,159.84
 营业税金及附加(元) 会员可见会员可见会员可见会员可见4,817,189.812,565,900.25
 销售费用(元) 会员可见会员可见会员可见会员可见12,495,765.846,658,786.67
 管理费用(元) 会员可见会员可见会员可见会员可见41,292,932.9122,091,198.78
 财务费用(元) 会员可见会员可见会员可见会员可见12,668,333.286,773,432.69
  其中:利息费用(元) 会员可见会员可见会员可见会员可见14,067,040.087,380,489.75
三、其他经营收益
 加:公允价值变动收益(元) ---会员可见-15,000.00-15,000.00
 加:投资收益(元) 会员可见会员可见会员可见会员可见46,557.2742,833.97
 资产处置收益(元) 会员可见会员可见会员可见会员可见-525,780.8147,178.05
 资产减值损失(元) 会员可见会员可见会员可见会员可见-9,152,677.49-7,134,563.27
 信用减值损失(元) 会员可见会员可见会员可见会员可见-1,806,133.82369,570.88
 其他收益(元) 会员可见会员可见会员可见会员可见2,546,833.451,500,621.93
四、营业利润(元) 会员可见会员可见会员可见会员可见34,987,428.0118,033,204.78
 加:营业外收入(元) 会员可见会员可见会员可见会员可见43,641.168,783.12
 减:营业外支出(元) 会员可见会员可见会员可见会员可见841,890.3113,095.89
五、利润总额(元) 会员可见会员可见会员可见会员可见34,189,178.8618,028,892.01
 减:所得税费用(元) 会员可见会员可见会员可见会员可见9,354,578.454,338,907.00
六、净利润(元) 会员可见会员可见会员可见会员可见24,834,600.4113,689,985.01
(一)按经营持续性分类
  持续经营净利润(元) 会员可见会员可见会员可见会员可见24,834,600.4113,689,985.01
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 会员可见会员可见会员可见会员可见24,834,600.4113,689,985.01
 扣除非经常性损益后的净利润(元) 会员可见会员可见会员可见会员可见-16,459,700.00
七、每股收益
 一、基本每股收益(元) 会员可见会员可见会员可见会员可见0.310.17
 二、稀释每股收益(元) 会员可见会员可见会员可见会员可见0.310.17
九、综合收益总额(元) 会员可见会员可见会员可见会员可见24,834,600.4113,689,985.01
 归属于母公司所有者的综合收益总额(元) 会员可见会员可见会员可见会员可见24,834,600.4113,689,985.01
公告日期 2026-08-262026-04-282025-08-272025-04-282025-08-272024-09-30
审计意见(境内) -标准无保留意见-标准无保留意见-标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院